Nanoparticle technology for drug delivery across the blood-brain barrier

Drug Development and Industrial Pharmacy

Volumn 28, Issue 1, 2002, Pages 1-13

  Lockman, P R ^a   Mumper, R J ^b   Khan, M A ^a   Allen, D D ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; NANOPARTICLE; POLYMER; SURFACTANT;

ANESTHESIA; BLOOD BRAIN BARRIER; COLLOID; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG MANUFACTURE; DRUG MECHANISM; DRUG MONITORING; DRUG PENETRATION; DRUG TRANSPORT; HUMAN; MACROMOLECULE; MOLECULAR SIZE; NANOTECHNOLOGY; OPSONIZATION; PERIPHERAL NEUROPATHY; PHAGOCYTOSIS; POLYMERIZATION; RETICULOENDOTHELIAL SYSTEM; REVIEW; SLOW DRUG RELEASE; SURFACE TENSION;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CENTRAL NERVOUS SYSTEM AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; NANOTECHNOLOGY;

EID: 0036205158     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120001481     Document Type: Review

References (47)

1. Electrical resistance across the blood-brain barrier in anaesthetized rats: A developmental study
2. Advances in neurology
3. 14C] sucrose after osmotic opening of the blood-brain barrier
4. Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7
5. Drug delivery to the brain by blood-brain barrier circumvention. Drug modification
6. Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain
7. Rapid high affinity transport of a chemotherapeutic amino acid across the blood-brain barrier
8. Drug delivery to the brain and the role of carrier mediated transport
9. P-glycoprotein: A defense mechanism limiting oral bioavailability and CNS accumulation of drugs
10. Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient-case report
11. Distribution of nerve growth factor following direct delivery to brain interstitum
12. The aged monkey basal forebrain: Rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor
13. Drug streaming during intra-arterial chemotherapy
14. Nanoparticles and microparticles for drug and vaccine delivery
15. Nanoparticles
16. Large scale production problems and manufacturing of nanoparticles
17. Polymerized micelles and their use as adjuvants in immunology
18. Development of a new process for the manufacture of polyisobutyl-cyanoacrylate nanoparticles
19. Nanocapsule formulation by interfacial deposition following solvent displacement
20. Incorporation of water-soluble drugs in albumin microspheres
21. Preparation of metabolizable radioactive human serum albumin microspheres for studies of the circulation
22. Nanoparticles - A new colloidal drug delivery system
23. Solid lipid nanoparticles for controlled drug delivery: Production, characterization and sterilization
24. Solid lipid nanoparticles - An alternative colloidal carrier for controlled drug delivery
25. Quantitation of the release of doxorubicin from colloidal drug forms using dynamic dialysis
26. Particle size and distribution of poly(butyl-2-cyanoacrylate) nanoparticles II. Influence of stabilizers
27. Influence of the particle size on the adjuvant effects of polybutylcyanoacrylate nanoparticles
28. Evaluation of effect of charge and lipid coating on ability of 60 nm nanoparticles to cross an in vitro model of the blood-brain barrier
29. Nanoparticle technology for delivery of drugs across the blood-brain barrier
30. Analgesic activity of the hexapeptide dalagrin adsorbed on the surface of polysorbate-80 coated polybutylcyanoacrylate nanoparticles
31. Passage of peptides through the blood-brain barrier with colloidal particles (nanoparticles)
32. Uptake of surfactant-coated poly-methyl-methylacrylate nanoparticles by bovine brain microvessel endothelial cell monolayers
33. Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human, bovine, and murine primary brain capillary endothelial cells
34. Nanoparticulate systems for brain delivery of drugs
35. Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalagrin injections
36. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate-80 coated polybutylcyanoacrylate nanoparticles: An in situ brain perfusion study
37. Significant transport of doxorubicin into the brain with polysorbate-80 coated nanoparticles
38. Chemotherapy of brain tumors using doxorubicin bound to polysorbate-80 coated nanoparticles
39. Body distribution in mice of intravenously injected camphotothericin solid lipid nanoparticles and targeting effect on the brain
40. Pharmacokinetics and distribution of a biodegradable drugcarrier
41. Targeted delivery of low dose doxorubicin hydrochloride administered via magnetic albumin microspheres in rats
42. Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres
43. Modification of the body distribution of poly(methyl methyl methylacrylate) nanoparticles by coating with surfactants
44. Indirect evidence that drug brain targeting using polysorbate-80 coated polybutylcyanoacrylate nanoparticles is related to toxicity
45. Stark The diagnosis of splenic lymphoma by MR imaging: Value of superparamagnetic iron oxide
46. Influence of nanoparticles on the brain-to-serum distribution and the metabolism of valproic acid in mice
47. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: Pharmacokinetics and tissue distribution after i.v. administration to rats